<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Systemic anaplastic large cell lymphoma: Post-induction management of advanced-stage disease in transplant-eligible patients</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Systemic anaplastic large cell lymphoma: Post-induction management of advanced-stage disease in transplant-eligible patients</h1>
<div class="graphic"><div class="figure"><div class="ttl">Systemic anaplastic large cell lymphoma: Post-induction management of advanced-stage disease in transplant-eligible patients</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm describes post-induction therapy management of advanced-stage ALK-positive sALCL and ALK-negative sALCL in transplant-eligible patients. Refer to related UpToDate material for details of diagnosis, staging, prognosis, treatment, eligibility for HCT, and response assessment. Management of relapsed or refractory sALCL is discussed separately.</div><div class="graphic_footnotes"><p>sALCL: systemic anaplastic large cell lymphoma; ALK: anaplastic lymphoma kinase; PET: positron emission tomography; CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; HCT: hematopoietic cell transplantation.</p>
<p>* The choice of observation versus autologous HCT in this setting must be individualized.</p>
<p>¶ A single site of persistent disease amenable to radiation therapy.</p>
Δ HCT followed by radiation therapy is also acceptable.</div><div id="graphicVersion">Graphic 142625 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
